References
- 1Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014; 370: 1790–8. DOI: 10.1056/NEJMoa1400590
- 2Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019; 380: 1695–705. DOI: 10.1056/NEJMoa1814052
- 3Tamburino C, Bleiziffer S, Thiele H, Scholtz S, Hildick-Smith D, Cunnington M, et al. Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: The SCOPE 2 Randomized Clinical Trial. Circulation. 2020. DOI: 10.1161/CIRCULATIONAHA.120.051547
- 4Sharma SK, Rao RS, Chandra P, Goel PK, Bharadwaj P, Joseph G, et al. First-in-human evaluation of balloon expandable transcatheter heart valve in the treatment of severe symptomatic native aortic stenosis: The MyVal-1 Study. EuroIntervention. 2019. DOI: 10.4244/EIJ-D-19-00413
- 5Tateishi H, Campos CM, Abdelghani M, Leite RS, Mangione JA, Bary L, et al. Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: Results from the Brazilian TAVI registry. EuroIntervention. 2016; 11: 1409–18. DOI: 10.4244/EIJV11I12A271
- 6Abdel-Wahab M, Abdelghani M, Miyazaki Y, Holy EW, Merten C, Zachow D, et al. A novel angiographic quantification of aortic regurgitation after TAVR provides an accurate estimation of regurgitation fraction derived from cardiac magnetic resonance imaging. JACC Cardiovasc Interv. 2018; 11: 287–97. DOI: 10.1016/j.jcin.2017.08.045
- 7Modolo R, Chang CC, Tateishi H, Miyazaki Y, Pighi M, Abdelghani M, et al. Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: Results of the multicentre ASSESS-REGURGE Registry. EuroIntervention. 2019; 15: 420–6. DOI: 10.4244/EIJ-D-19-00362
- 8Modolo R, Chang CC, Abdelghani M, Kawashima H, Ono M, Tateishi H, et al. Quantitative assessment of acute regurgitation following TAVR: A multicenter pooled analysis of 2,258 valves. JACC Cardiovasc Interv. 2020; 13: 1303–11. DOI: 10.1016/j.jcin.2020.03.002
- 9Modolo R, van Mourik M, El Bouziani A, Kawashima H, Rosseel L, Abdelghani M, et al. Online quantitative aortographic assessment of aortic regurgitation after TAVR: Results of the OVAL Study. JACC Cardiovasc Interv. 2021. DOI: 10.1016/j.jcin.2020.11.014
- 10Kawashima H, Soliman O, Wang R, Ono M, Hara H, Gao C, et al. Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trial. Am Heart J. 2020; 232: 23–38. DOI: 10.1016/j.ahj.2020.11.001